Targeting PD-1/PD-L1 in lung cancer: current perspectives

María González-Cao1 Translational Cancer Research Unit, Instituto Oncológico Dr Rosell, Quirón Dexeus University Hospital, Barcelona, SpainCorrespondence[email protected]

Niki Karachaliou1 Translational Cancer Research Unit, Instituto Oncológico Dr Rosell, Quirón Dexeus University Hospital, Barcelona, Spain

Santiago Viteri1 Translational Cancer Research Unit, Instituto Oncológico Dr Rosell, Quirón Dexeus University Hospital, Barcelona, Spain

Daniela Morales-Espinosa1 Translational Cancer Research Unit, Instituto Oncológico Dr Rosell, Quirón Dexeus University Hospital, Barcelona, Spain

Cristina Teixidó2 Pangaea Biotech SL, Barcelona, Spain

Jesús Sánchez Ruiz3 Centro Nacional de Investigación Oncología (CNIO), Madrid, Spain

Miquel Ángel Molina-Vila2 Pangaea Biotech SL, Barcelona, Spain

Mariacarmela Santarpia4 Medical Oncology Unit, Human Pathology Department, University of Messina, Messina, Italy

Rafael Rosell1 Translational Cancer Research Unit, Instituto Oncológico Dr Rosell, Quirón Dexeus University Hospital, Barcelona, Spain;2 Pangaea Biotech SL, Barcelona, Spain;5 Cancer Biology and Precision Medicine Program, Catalan Institute of Oncology, Germans Trias i Pujol Health Sciences Institute and Hospital, Campus Can Ruti, Badalona, Barcelona, Spain;6 Fundación Molecular Oncology Research, Barcelona, Spain

show all

Targeting PD-1/PD-L1 in lung cancer: current perspectives

Articles from other publishers (1)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Targeting PD-1/PD-L1 in lung cancer: current perspectives

Citations (1)

Articles from other publishers (1)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date